CAMCEVI 42 mg prolonged-release suspension for injection

Licence status
Authorised: 24/06/2022
Active substances
Leuprorelin Mesilate, Leuprorelin
Dosage Form
Prolonged-release suspension for injection
Licence number
EU/1/22/1647/001
Licence holder
Accord Healthcare S.L.U.

Product documents

Licence information

ATC code
L02AE02 leuprorelin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
24/06/2022